Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LYKA LABS Fact Sheet  (LYLB)



Access Now: Equitymaster's Premium Small Cap Research at 50% Off


Here is the latest financial fact sheet of LYKA LABS. For more details, see the LYKA LABS quarterly results and LYKA LABS share price. For a sector overview, read our pharmaceuticals sector report.

LYKA LABS Price History

Price Rs 104.6
Mkt Cap Rs m 3,461
Vol '000 73.8
P/E X -26.3
P/CF X 6.2
EPS (TTM) Rs -4.0
1 Day % 8.8
No. of shares m 33.09
1 Week % 16.9
1 Month % 1.4
1 Year % -15.5
52 week H/L Rs 165.0/89.0
As on Jun 2, 2023 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LYKA LABS Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
LYKA LABS EQUITY SHARE DATA
High Rs82523536267 
Low Rs3921101325 
Sales per share (Unadj.) Rs21.025.221.430.167.6 
Earnings per share (Unadj.) Rs-6.8-2.3-21.8-3.513.4 
Diluted earnings per shareRs-5.7-1.9-18.9-3.011.6 
Cash flow per share (Unadj.) Rs-2.70.3-19.0-0.619.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs17.315.0-5.0-9.04.6 
Adj. book value per shareRs14.712.8-4.3-7.84.0 
Shares outstanding (eoy) m28.1428.1428.6928.6928.69 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x2.91.51.00.82.2 
Avg P/E ratio x-8.9-16.3-1.0-6.910.9 
P/CF ratio (eoy) x-22.0107.4-1.2-39.37.5 
Price / Book Value ratio x3.52.4-4.5-2.731.4 
Dividend payout %00000 
Avg Mkt Cap Rs m1,6961,0336456944,189 
No. of employees `000NANANANANA 
Total wages/salary Rs m170147139146181 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
LYKA LABS INCOME DATA
Net Sales Rs m5907086158631,941 
Other income Rs m2121311621 
Total revenues Rs m6117296468781,962 
Gross profit Rs m-13-30-369186946 
Depreciation Rs m113738083173 
Interest Rs m9672201259201 
Profit before tax Rs m-200-154-619-141592 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-10-917-41208 
Profit after tax Rs m-190-64-626-101384 
Gross profit margin %-2.2-4.3-60.021.548.8 
Effective tax rate %5.258.8-1.228.735.1 
Net profit margin %-32.2-9.0-101.8-11.719.8 
LYKA LABS BALANCE SHEET DATA
Current assets Rs m491351359291522 
Current liabilities Rs m1,671848663499994 
Net working cap to sales %-200.1-70.2-49.5-24.1-24.3 
Current ratio x0.30.40.50.60.5 
Inventory Days Days1991491168741 
Debtors Days Days1,268754477367347 
Net fixed assets Rs m1,7621,6771,5201,4461,334 
Share capital Rs m281281287287287 
"Free" reserves Rs m206141-430-545-154 
Net worth Rs m487423-143-258133 
Long term debt Rs m497931,2611,514625 
Total assets Rs m2,2522,0291,8791,7371,856 
Interest coverage x-1.1-1.2-2.10.53.9 
Debt to equity ratio x0.11.9-8.8-5.94.7 
Sales to assets ratio x0.30.30.30.51.0 
Return on assets %-4.20.4-22.69.131.6 
Return on equity %-39.0-15.0436.539.1288.2 
Return on capital %-19.5-6.8-37.49.4104.7 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
LYKA LABS CASH FLOW
From Operations Rs m 109 267 53 88 792 
From Investments Rs m -32 -40 -1 -2 -62 
From Financial Activity Rs m -104 -234 34 -118 -632 
Net Cashflow Rs m -27 -7 86 -31 99 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.0%
Institution 3.9%
Non-Institution 45.1%
Total 100.0%
Free Float 49.0%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2023
 

Company Information

Regd Off 4801/B & 4802/A, G I D C Industrial Estate, Ankleshwar - 393002
E-mail companysecretary@lykalabs.com Web www.lykalabs.com
Tel 02646221422 /220549 Fax 02646-250692
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, L B S Marg, Vikhroli (West)
Auditor C. C. Chokshi & Co.
CHM: Kunal N Gandhi COMP SEC: Kishore P Shah YEAR OF INC: 1976 BSE CODE: 500259 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA    CIPLA    PIRAMAL ENTERPRISES    LUPIN    DR. REDDYS LAB    

Compare LYKA LABS With:   AUROBINDO PHARMA    CIPLA    PIRAMAL ENTERPRISES    LUPIN    DR. REDDYS LAB    




Today's Market

Sensex Today Ends 119 Points Higher | Nykaa Gains 7%, Zomato 3% | Hindalco & Hero MotoCorp Among Top Gainers Sensex Today Ends 119 Points Higher | Nykaa Gains 7%, Zomato 3% | Hindalco & Hero MotoCorp Among Top Gainers(Closing)

After opening the day flat, Indian share markets picked up pace as session progressed and ended the day higher.